Prognostic information can be obtained from the subtype classification (estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 receptor [HER2]), tumor stage and, in some cases genomic tests [2]. This evidence concerns the gene ESR1 and neoplasm.